Advanced Enzyme Technologies Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: ADVENZYMES BSE: 540025

About Advanced Enzyme Technologies Limited

No company profile on record yet.

Key facts

BSE symbol540025
NSE symbolADVENZYMES
ISININE837H01020
CINL24200MH1989PLC051018
Listing date1 Aug 2016
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorShiv Hari Jalan & Co. (Shiv Hari Jalan)
Registered officeSUN MAGNECTICA, 5TH FLOOR, NEAR LIC SERVICE ROAD, LOUIS WADI
Registrar & transfer agentMUFG Intime India Private Limited C-101, 247 PARK, L.B.S. MARG, VIKHROLI (WEST)

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)516†413†—321†282†
Net profit1321021085655†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Mukund Madhusudan KabraExecutive DirectorJune 30, 2026
Nitin Jagannath DeshmukhIndependent DirectorJune 30, 2026
Pradip Bhailal ShahIndependent DirectorJune 30, 2026
Pramod KasatIndependent DirectorJune 30, 2026
Vandana R TilakIndependent DirectorJune 30, 2026
Vinodkumar Hiralal JajooIndependent DirectorJune 30, 2026
Rasika RathiNon-Executive DirectorJune 30, 2026
Sunny SharmaNon-Executive DirectorJune 30, 2026
Vasant L RathiNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.